SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Genaera Corp – ‘S-3/A’ on 6/11/99 – EX-23.2

On:  Friday, 6/11/99   ·   Accession #:  1036050-99-1268   ·   File #:  333-75991

Previous ‘S-3’:  ‘S-3’ on 4/9/99   ·   Next:  ‘S-3/A’ on 6/28/99   ·   Latest:  ‘S-3/A’ on 3/23/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/11/99  Genaera Corp                      S-3/A                  2:66K                                    Donnelley R R & S… 14/FA

Pre-Effective Amendment to Registration Statement for Securities Offered Pursuant to a Transaction   —   Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3/A       Maganinin Pharmaceuticals Inc. Amendment No. 1        24    101K 
 2: EX-23.2     Consent of Kpmg LLP                                    1      4K 


EX-23.2   —   Consent of Kpmg LLP

EX-23.2TOCTopPreviousNextBottomJust 1st
 

Exhibit 23.2 Consent of Independent Certified Public Accountants --------------------------------------------------- The Board of Directors Magainin Pharmaceuticals Inc.: We consent to the use of our report incorporated herein by reference and to the reference to our firm under the heading "Experts" in the prospectus. KPMG LLP Princeton, New Jersey June 8, 1999

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3/A’ Filing    Date    Other Filings
Filed on:6/11/99None on these Dates
6/8/99
 List all Filings 
Top
Filing Submission 0001036050-99-001268   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 2:49:38.2pm ET